Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, FVT

Prognos Launches Signal Solution at DigiPharma Connect Conference


NEW YORK, Feb. 22, 2019 /PRNewswire/ -- Prognos announced the launch of a groundbreaking digital solution today that will help life science brands use real-world diagnostic alerts to treat patients more efficiently. The healthcare AI company will introduce the product at the DigiPharma Connect Conference, a forum for senior-level digital marketers in pharmacy and biotech, which will be held February 25th through 27th.

Prognos logo (PRNewsfoto/Prognos)

Signal is the first clinically-relevant digital alert powered by AI that enables life science brands to extend reach and optimize programmatic advertising engagement with health care providers. It uses the Prognos Registry of more than 20 billion unique clinical records and advanced AI applications.

"This is the first time life science brands are able to harness near-real time clinical insights to act while treatment decisions are being made," says Matt Apprendi, Vice President of Digital Products for Prognos. "They can synchronize messaging to health care providers across personal, non-personal and digital advertising channels. Early adopters are using Prognos' Signal to gain a competitive advantage so they can be relevant and top of mind at the right time."

The new product furthers Prognos' goal of improving health by predicting disease the earliest.  "Prognos' Signal provides a compelling solution that marries timely diagnostic data with AI insights to power the digital strategies for life science brands," says Theresa Greco, CCO of Prognos.

About Prognos

Prognos is a healthcare AI company focused on predicting disease to drive decisions earlier in healthcare in collaboration with payers, Life Sciences and diagnostics companies. The Prognos Registry is the largest source of clinical diagnostics information in 50 disease areas, with over 20 billion medical records for 200 million patients. Prognos has 1,000 extensive proprietary and learning clinical algorithms to enable earlier patient identification for enhanced treatment decision-making, risk management and quality improvement. The company is supported by a $42M investment from Safeguard Scientifics, Inc., Merck Global Health Innovation Fund, Cigna, GIS Strategic Ventures, Hikma Ventures, Hermed Capital, and Maywic Select Investments. For more information, visit www.prognos.ai.

Media contact:
Heather Kerr
(203) 504-8230
[email protected]

SOURCE Prognos


These press releases may also interest you

at 15:38
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
Automation Anywhere, a leader in AI-powered automation solutions, announced that AI marketing leader ?Tim McDonough joined the company as chief marketing officer (CMO). McDonough, who brings more than two decades of experience in driving growth...

at 15:25
Invenco by GVR, A Vontier Company, Opens State-Of-The-Art Engineering Center for 250 Employees in Bengaluru, India
Vontier Corporation , a leading global provider of critical technologies and solutions to connect, manage and scale the mobility ecosystem, announces the opening of a state-of-the-art engineering office for Invenco by GVR in Bengaluru, India this...

at 15:16
First-Ever T.I.R.E. Summit to Convene Technology Leaders for Enhanced Tire Safety and Efficiency
Anyline, a global leader in AI-powered mobile data capture and data insights, is inviting leaders from the tire, fleet management and automotive service industries to participate in a first-of-its-kind T.I.R.E. Summit. The one-day event, which will...

at 15:14
Cymbiotika Launches New Pet Line, Elevating Pet Health with 4 New Supplements: Probiotic+, Calm, Hip & Joint, and Allergy & Immune Health
Cymbiotika, a trailblazer in health and wellness, is thrilled to announce the launch of its new pet line, meticulously crafted to enhance the health and vitality of beloved pets. The new line includes four revolutionary products: Probiotic+, Calm,...

at 15:14
AccountTECH unveils revolutionary Cloud-Based Enterprise Accounting software at the T3 Leadership Summit
Fintech Breakthrough: CFOs and franchise operators have long been searching for a comprehensive, web based accounting solution that can meet G.A.A.P. requirements of large, complex organizations. AccountTECH has...

at 15:14
FLOKI Now Listed On Europe's Leading Neobank Revolut
In a significant expansion of its cryptocurrency portfolio, Revolut, a frontrunner in Europe's neobank sector, has added the FLOKI token to its platform. This move opens up avenues for over 40 million users across more than 150 countries to engage...

More news about Science and technology...


News published on and distributed by: